[In Context] Marc Tardieu: the interface man

“To be a doctor is also to be an activist”, Marc Tardieu told me. Coming from anyone else this might appear a surprising statement. But not from this mixer and masher of paediatric neurology, neurovirology, neuroimmunology, and patient-association advocacy. “Well, I like to be at the interface of things”, he says. One glance at the paper on mucopolysaccharidosis IIIB he coauthors in this issue of The Lancet Neurology—an innovative gene therapy trial for treatment of a rare disease that induces severe disability in children, and which required a large team working at the intersection between many specialities—should dispel any doubt of that.
Source: Lancet Neurology - Category: Neurology Authors: Tags: In Context Source Type: research